M. Suttle

Is there a role for mast cells in psoriasis?

G. Nilsson, A. Naukkarinen, I. Harvima, 2008, Archives of Dermatological Research.

Experimentally induced psoriatic lesion associates with interleukin (IL)‐6 in mast cells and appearance of dermal cells expressing IL‐33 and IL‐6 receptor

G. Nilsson, E. Snellman, I. Harvima, 2012, Clinical and experimental immunology.

Epidermal Expression of Filaggrin/Profilaggrin Is Decreased in Atopic Dermatitis: Reverse Association With Mast Cell Tryptase and IL-6 but Not With Clinical Severity

V. Tiitu, I. Harvima, T. Ilves, 2015, Dermatitis : contact, atopic, occupational, drug.

CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas

J. Pelkonen, I. Harvima, Antti Kaukinen, 2017, Cancer investigation.

Mast cell chymase in experimentally induced psoriasis

I. Harvima, M. Suttle, 2016, The Journal of dermatology.

Increase in FoxP3-positive Cells and Their Contacts with Mast Cells in Köbner-negative Patients with Psoriasis after Tape-stripping.

I. Harvima, M. Suttle, R. Ritanen, 2019, Acta dermato-venereologica.

Increase in FoxP3-positive Cells and Their Contacts with Mast Cells in Köbner-negative Patients with Psoriasis after Tape-stripping.

I. Harvima, M. Suttle, R. Ritanen, 2019, Acta dermato-venereologica.

Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis.

G. Nilsson, Mattias Enoksson, I. Harvima, 2015, Acta dermato-venereologica.